博九娱乐网

CENTOGENE engages in diagnosis and research around rare diseases transforming real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. Their goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their extensive rare disease knowledge, including epidemiological and…More clinical data, as well as innovative biomarkers. CENTOGENE has developed a global proprietary rare disease platform based on their real-world data repository with approximately 3.0 billion weighted data points from over 530,000 patients representing over 120 different countries as of March 31, 2020.